首页> 美国卫生研究院文献>Journal of Neurotrauma >Phenelzine Protects Brain Mitochondrial Function In Vitro and In Vivo following Traumatic Brain Injury by Scavenging the Reactive Carbonyls 4-Hydroxynonenal and Acrolein Leading to Cortical Histological Neuroprotection
【2h】

Phenelzine Protects Brain Mitochondrial Function In Vitro and In Vivo following Traumatic Brain Injury by Scavenging the Reactive Carbonyls 4-Hydroxynonenal and Acrolein Leading to Cortical Histological Neuroprotection

机译:苯乙肼通过清除反应性羰基4-羟基壬烯醛和丙烯醛导致皮层组织神经保护在创伤性脑损伤后体外和体内保护脑线粒体功能。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lipid peroxidation (LP) is a key contributor to the pathophysiology of traumatic brain injury (TBI). Traditional antioxidant therapies are intended to scavenge the free radicals responsible for either initiation or propagation of LP. A more recently explored approach involves scavenging the terminal LP breakdown products that are highly reactive and neurotoxic carbonyl compounds, 4-hydroxynonenal (4-HNE) and acrolein (ACR), to prevent their covalent modification and rendering of cellular proteins nonfunctional leading to loss of ionic homeostasis, mitochondrial failure, and subsequent neuronal death. Phenelzine (PZ) is a U.S. Food and Drug Administration–approved monoamine oxidase (MAO) inhibitor (MAO-I) used for treatment of refractory depression that possesses a hydrazine functional group recently discovered by other investigators to scavenge reactive carbonyls. We hypothesized that PZ will protect mitochondrial function and reduce markers of oxidative damage by scavenging LP-derived aldehydes. In a first set of in vitro studies, we found that exogenous application of 4-HNE or ACR significantly reduced respiratory function and increased markers of oxidative damage (p < 0.05) in isolated noninjured rat brain cortical mitochondria, whereas PZ pre-treatment significantly prevented mitochondrial dysfunction and oxidative modification of mitochondrial proteins in a concentration-related manner (p < 0.05). This effect was not shared by a structurally similar MAO-I, pargyline, which lacks the hydrazine group, confirming that the mitochondrial protective effects of PZ were related to its carbonyl scavenging and not to MAO inhibition. In subsequent in vivo studies, we documented that PZ treatment begun at 15 min after controlled cortical impact TBI significantly attenuated 72-h post-injury mitochondrial respiratory dysfunction. The cortical mitochondrial respiratory protection occurred together with a significant increase in cortical tissue sparing.
机译:脂质过氧化(LP)是创伤性脑损伤(TBI)病理生理的关键因素。传统的抗氧化剂疗法旨在清除负责LP引发或繁殖的自由基。最近开发的一种方法涉及清除末端LP分解产物,这些产物是具有高反应性和神经毒性的羰基化合物,4-羟基壬烯醛(4-HNE)和丙烯醛(ACR),以防止它们的共价修饰和使细胞蛋白失去功能,从而导致丧失离子稳态,线粒体衰竭和随后的神经元死亡。苯乙肼(PZ)是美国食品药品监督管理局批准的单胺氧化酶(MAO-I)抑制剂,用于治疗难治性抑郁症,该抑制剂具有肼官能团,最近其他研究人员发现该肼官能团可清除活性羰基。我们假设PZ将通过清除LP衍生的醛来保护线粒体功能并减少氧化损伤的标志物。在第一批体外研究中,我们发现外源应用4-HNE或ACR可以显着降低单独的未损伤大鼠大脑皮质线粒体的呼吸功能并增加氧化损伤的标志物(p <0.05),而PZ预处理则可以显着预防线粒体功能障碍和线粒体蛋白质的氧化修饰以浓度相关的方式(p <0.05)。缺少肼基的结构相似的MAO-1 Pargyline没有共享这种作用,这证实PZ的线粒体保护作用与其羰基清除作用有关,而与MAO抑制作用无关。在随后的体内研究中,我们记录了在受控的皮质撞击TBI后15分钟开始PZ治疗可显着减轻损伤后线粒体呼吸功能障碍的72小时。发生皮质线粒体呼吸保护,同时皮质组织保留量显着增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号